Pharmacogenomic Testing to Select Antiplatelet Therapy

被引：9
|
作者：
Price, Matthew J. [1 ]
Angiolillo, Dominick J. [2 ]
机构：
[1] Scripps Clin, Div Cardiovasc Dis, 9898 Genesee Ave,AMP 200, La Jolla, CA 92037 USA
[2] Univ Florida, Div Cardiol, Jacksonville, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 17期
关键词：
acute coronary syndrome; antiplatelet therapy; clopidogrel; pharmacogenomics; platelet function testing; platelet reactivity; prasugrel; thienopyridine; ticagrelor; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; DOSE CLOPIDOGREL; GENETIC POLYMORPHISMS; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; TICAGRELOR; PRASUGREL; STANDARD; IMPLANTATION;
D O I：
10.1016/j.jacc.2018.03.021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1878 / 1881
页数：4
相关论文
共 50 条
  • [31] Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer
    Pusztai Lajos
    Fraser W. Symmans
    Gabriel N. Hortobagyi
    Breast Cancer, 2005, 12 (2) : 73 - 85
  • [32] Molecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications
    Di Francia, Raffaele
    Berretta, Massimiliano
    Catapano, Oriana
    Canzoniero, Lorella M. T.
    Formisano, Luigi
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (07) : 1105 - 1111
  • [33] Adoption of Pharmacogenomic Testing: A Marketing Perspective
    Koufaki, Margarita-Ioanna
    Karamperis, Kariofyllis
    Vitsa, Polixeni
    Vasileiou, Konstantinos
    Patrinos, George P.
    Mitropoulou, Christina
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [34] Erlotinib and patterns of pharmacogenomic (PGx) testing
    De Souza, Jonas A.
    Gleason, Patrick P.
    Starner, Catherine I.
    Qiu, Yang P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [35] Pharmacogenomic Testing and Personalized Treatment of Depression
    Perlis, Roy H.
    CLINICAL CHEMISTRY, 2014, 60 (01) : 53 - 59
  • [36] Misleading Guidance From Pharmacogenomic Testing
    Rahman, Tahir
    Ash, David M.
    Lauriello, John
    Rawlani, Roshni
    AMERICAN JOURNAL OF PSYCHIATRY, 2017, 174 (10): : 922 - 924
  • [37] The challenges of implementing pharmacogenomic testing in the clinic
    Moyer, Ann M.
    Caraballo, Pedro J.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (06) : 567 - 577
  • [38] Insurance coverage for pharmacogenomic testing in the USA
    Williams, Marc S.
    PERSONALIZED MEDICINE, 2007, 4 (04) : 479 - 487
  • [39] DIFFERENT STAKEHOLDER PERSPECTIVES ON PHARMACOGENOMIC TESTING
    Patel, H.
    Ursan, I
    Zueger, P.
    Pickard, A. S.
    VALUE IN HEALTH, 2013, 16 (03) : A244 - A244
  • [40] Platelet Function Testing in Patients on Antiplatelet Therapy before Cardiac Surgery
    Mahla, Elisabeth
    Tantry, Udaya S.
    Schoerghuber, Michael
    Gurbel, Paul A.
    ANESTHESIOLOGY, 2020, 133 (06) : 1263 - 1276
12345